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Background:  A summary of factors associated with recurrent tuberculosis (TB) in the African HIV-infected population is 
lacking. We performed a systematic review to address this. 
Methods: We performed a literature search within PubMed and The WHO Global Library with specific inclusion and ex- 
clusion criteria to identify manuscripts emanating from the African continent which potentially described factors associated with 
recurrent TB in persons living with HIV. 
Results: The literature search yielded 52 unique manuscripts, of which only 4 manuscripts were included in the final sys- 
tematic review following application of the inclusion and exclusion criteria. Baseline CD4 count, baseline HIV viral load, a 
positive tuberculin skin test, prior active TB disease, cutaneous hypersensitivity reaction to treatment, having < 3 lung zones 
affected by prior TB disease, and anaemia were associated with recurrent TB in HIV-infected individuals, whilst age and 
antiretroviral status were not. 
Conclusion:  The lack of studies describing recurrent TB in Africa which stratify results by HIV-status is a hindrance to 
understanding risk factors for recurrent TB in this population. This might be overcome by implementing guidelines related to 
the publishing of data from observational studies in peer-reviewed medical journals reporting recurrent TB in populations with a 
high-burden of HIV infection. 
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Tuberculosis (TB) is a global health problem, with the 
African population amongst the populations with the 
highest burden of TB disease.1  This appears to be re- 
lated to the high burden of HIV on the African conti- 
nent. Indeed, HIV infection substantially increases the 
risk of developing future TB disease.1   Therefore, even 
HIV-infected individuals with a previous history of TB 
who might have been cured or successfully completed 
their TB treatment might develop TB again during their 
lifetime.   This “recurrent” TB infection might be due 
to 1) a newly acquired infection with Mycobacterium 
tuberculosis following prior successful treatment for 
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losis from a previous exposure which did not result in 
active TB disease, or 3) activation of latent M. tubercu- 
losis which remained following treatment completion 
for a prior episode of active TB disease.2 Persons with 
HIV infection have a higher risk of recurrent TB dis- 
ease.1 In addition, there is significant mortality from TB 
infection in HIV infected persons.3   It is therefore im- 
portant to identify additional factors associated with re- 
current TB in the HIV-infected population to aid in the 
development of  efficient risk-reduction interventions. 
The aim of this study was to conduct a systematic re- 
view of the published literature in order to identify ad- 
ditional risk factors for recurrent TB infection in people 
living with HIV/AIDS in Africa. 
 
Methods 
A formally registered protocol for this systematic review is 
unavailable.  Briefly, we conducted  a parallel search of 
PubMed and The WHO Global Library.    In PubMed 
we searched using a combination of phrases/keywords 
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Table 1.  Electronic search strategy 
 
Database Query Search Terms Number     of     Items 
Returned 
PubMed 1 Recurrence [MeSH Terms] 150497 
 2 Tuberculosis[MeSH Terms] 162792 
 3 HIV [MeSH Terms] 83568 
 4 Risk Factors [MeSH Terms] 592615 
 5 Africa [MeSH Terms] 191475 
 6 (((Recurrent)  OR  Recurrence)  OR 
Recurring) OR Relapse [All Fields] 
560062 
 7 Tuberculosis [All Fields] 219757 
 8 HIV [All Fields] 287733 
 9 (Risk  Factors)  OR  Predictors  [All 
Fields] 
1024743 
 10 Africa [All Fields] 249634 
 11 ((((Query #1) AND Query #2) AND 
Query  #3)  AND  Query  #4)  
AND Query #5 
5 
 12 ((((Query #6) AND Query #7) AND 
Query  #8)  AND  Query  #9)  
AND Query #10 
51 





1 (Recurrence  [MeSH  Terms])  AND 
(Tuberculosis [MeSH Terms]) AND 
(HIV [MeSH Terms]) 
AND (Risk Factors [MeSH Terms]) 
AND 
(Africa [MeSH Terms]) 
12 
 
We had chosen to search PubMed with both these op- 
tions to improve the sensitivity of the search. In addi- 
tion to the PubMed literature search, we also performed a 
search of literature in the World Health Organisation’s 
(WHO) Global Medical Library using the same MeSH 
terms used in the PubMed search. We were unable to 
search EMBASE as our institution does not have access 
to the database.  Abstracts of studies identified from 
the literature search were screened using the inclusion 
and exclusion criteria specified in Table 2.
 
Table 2.  Inclusion and exclusion criteria for this systematic review 
 
Inclusion Criteria Exclusion Criteria 
Original  manuscripts  published  in  English  in 
peer reviewed journals 
Unpublished data, review manuscripts, case 
reports, commentaries, non-English manuscripts 
Research conducted in Africa Research conducted outside Africa 
Studies reporting risk factors for recurrent TB in 
people living with HIV/AIDS 
Studies  which  do  not  report  risk  factors  for 
recurrent TB in people living with HIV/AIDS 
Studies conducted in the general population Research  which  does  not  involve  the  general 
population  or  focusses  on  specific  population 
groups (For example, miners) 
Research in adults Research in children 
 
 
The reference lists of included manuscripts were also 
hand searched for relevant studies which might not 
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Newcastle-Ottawa Scale. We did not extend our search 
to “grey area” literature. Our decision to exclude data 
from “grey area” literature might have introduced pub- 
lication bias, however the “grey area” literature is often 
not peer reviewed and in the case of  conference ab- 
stracts, may not have provided enough information to 
be included in the review. Two authors independently 
screened the articles for inclusion in the review, and the 
opinion of an expert would be sought in the event of a 
dispute. 
 
Manuscripts describing findings from  HIV-positive 
populations  (either  studies  solely of   HIV-infected 
populations, or studies which stratified results by HIV 
status) were reviewed and the relevant data abstracted 
where possible. In addition to key risk factors for re- 
current TB in HIV-infected individuals, the following 
data elements were extracted from all included manu- 
scripts: Author, country where the study was conduct- 
ed and year of publication; study design; size of HIV 
infected population; incidence of recurrent TB; % of 
cohort which was female; age; and CD4 count summa- 
ry.   Risk factors obtained from each study are primarily 
presented as a narrative. The characteristics of includ- 
ed studies are presented as descriptive statistics. 
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Results 
The results of our literature search of the two databas- 
es are illustrated in Figure 1. 
Our search yielded a total of 63 manuscripts. A total 
of  11 of  these manuscripts were duplicates.  Follow- 
ing review of the abstracts of the remaining 52 unique 
manuscripts,4-55 9 manuscripts7,15,18,23,25,26,31,33,35   were se- 
lected to undergo full text review. Reasons for exclu- 
sion of  43 manuscripts included:  Not original man- 
uscripts –  13  manuscripts;6,8,10,16,29,32,38,39,42,46,49,50,53    Not 
English –  3  manuscripts;30,40,45 Research in  children 
– 6 manuscripts;4,12,17,27,47,48   Do  not  describe findings 
from a general population – 6 manuscripts;5,14,21,37,41,51 
Studies which do not report risk factors for recurrent 
TB in people living with HIV/AIDS  – 14 manuscrip 
ts.9,11,13,19,20,22,24,28,36,43,44,52,54,55     In addition there was one 
manuscript which reported on leprosy.34 
Following full  text  screening of   the  9  manuscrip 
ts,7,15,18,23,25,26,31,33,35  there were 5 manuscripts which were 
found not to specifically report risk factors for recur- 
rent TB in people living with HIV/AIDS.7,15,26,33,35     In 
addition, we screened the reference lists of the remain- 
ing 4 manuscripts18,23,25,31  in order to identify other po- 
tentially eligible studies for inclusion in our systematic 
review, which did not yield any additional manuscripts. 
Therefore, this systematic review was comprised of 4 
eligible manuscripts.18,23,25,31 
A description of  all eligible manuscripts evaluated in 
this systematic review is shown in Table 3.
 
 




Study Design Total   sample  size 
analyzed        (HIV- 
positives only) 
Incidence       of 
recurrent     TB 
(/100 py) 
% Female Median Age Median 













979 HIV-positive with 




75.6 Median  age 








a prior history 









623 HIV-positive not 
on ART: 3.9 








Not specified 8 Performance 






Unclear 12      events/644 
person months 
and 11 events/704 
person months in 
HIV-infected 
persons with non- 
iron     deficiency 




Unclear Unclear Unclear 8 Selection, 
performance 




58 In patients with 
HIV-infection: 
16.7 
38.0% Not reported. 
65% of 
patients < 35 
years old. 










Risk factors for recurrent TB in people living  with 
HIV/AIDS were evaluated in participants from 4 stud- 
ies conducted in 3 countries in Africa (Kenya, Malawi 
and Tanzania).18,23,25,31   Three of the eligible manuscripts 
describe prospective observational studies.18,23,31 One 
manuscript described the secondary  analysis of  data 
obtained from a randomized controlled trial.25 Females 
comprised 38%,18  54%23  and 76%31  of  HIV-infected 
participants described in three of  the eligible manu- 
scripts.  The remaining manuscript did not stratify re- 
sults for gender by HIV status.25  The median age of 
HIV-infected participants in one manuscript was 36 
years old.31   Although median age was not specified in 
two manuscripts, approximately  half of  the HIV-in- 
fected study population was <35 years old in one man- 
uscript,23    while this proportion was 65% in another 
manuscript.18 The remaining manuscript did not strati- 
fy results for age by HIV status.25  Median CD4 counts 
were reported in one of the 4 manuscripts only.31 
 
There were several factors associated with a higher risk of 
developing recurrent TB infection identified in this 
systematic review. Risk factors for recurrent TB in peo- 
ple living with HIV/AIDS obtained from the full text 
review of eligible manuscripts are shown in Figure 2.
 
 




Most of  these risk factors were identified from the 
study of  Lahey et al,31  and included: Baseline CD4 
count, baseline HIV viral load, and a positive tubercu- 
lin skin test.  Factors which were not associated with a 
higher risk of recurrent TB in HIV-infected individuals 
reported in the study of  Lahey et al,31 included ART 
status and age. In their study, Houben and colleagues 
conducted a sub-analysis of  HIV-infected individuals 
but only investigated whether ART status was associat- 





with the study of Lahey et al,31 the study of Houben 
and colleagues did not identify an association between 
ART status and recurrent TB in HIV-infected individu- 
als.23 In the study conducted by Hawken and colleagues, 
there were two factors associated with a higher risk of 
recurrent TB in HIV-infected patients who had com- 
pleted treatment: cutaneous hypersensitivity reaction to 
treatment and < 3 lung zones affected by prior TB dis- 
ease.18 Isanaka et al., found that anaemia with or with- 
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increased risk of recurrent tuberculosis in HIV-infected 




Despite the high burden of  HIV-TB co-infection on 
the African continent, there appears to be very little 
published peer-reviewed literature related to identify- 
ing risk factors for recurrent TB in HIV-infected indi- 
viduals emanating from Africa. It is possible that the 
complexity of sharing data between TB and HIV pro- 
grams (which have traditionally been vertical programs at 
African health care facilities),56 makes research relat- ed 
to HIV-TB co-infection very difficult. Therefore it is 
likely that collaborative activities between HIV and TB 
health services which have been shown to improve 
patient outcomes,57  might also improve research efforts 
as a consequence. 
 
The risk factors for recurrent TB in HIV-infected in- 
dividuals identified in this systematic review were es- 
sentially extracted from four manuscripts18,23,25,31 and 
included baseline CD4 count, baseline HIV viral load, a 
positive tuberculin skin test, cutaneous hypersensitivity 
reaction to treatment, having < 3 lung zones affected by 
prior TB disease, and anaemia. The findings of this sys- 
tematic review have identified a gap in the current liter- 
ature and highlight the important role of future clinical 
studies studying recurrent TB in the HIV-infected pop- 
ulation.  Due to the insufficient number of published 
manuscripts identified during the literature search, we 
were unable to perform a meta-analysis which could 
have provided pooled risk estimates for risk factors as- 
sociated with recurrent TB in HIV-infected individuals in 
Africa.  This further highlights the need for more 
research initiatives aimed at identifying risk factors for 
recurrent TB in HIV-infected individuals living in Af- 
rica, and further efforts to disseminate the findings of 
these studies through peer-reviewed manuscripts to the 
wider scientific community.   This systematic review 
was also unable to provide information related to the 
stratification of recurrent TB into re-infection with M. 
tuberculosis or TB relapse. Before risk factors can be 
identified for these pathways leading to recurrent TB 
disease, adequately-powered  genetic studies in African 
populations are required to accurately determine the 
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Unfortunately, the lack of studies describing recurrent 
TB in Africa which stratify results by HIV-status is a 
hindrance to understanding risk factors for recurrent 
TB in this population.  It is possible that implement- 
ing guidelines related to the publishing of observational 
studies in peer-reviewed medical journals reporting re- 
current TB in populations with a high-burden of HIV 
infection might be a worthwhile approach to generating 
higher-level evidence for risk factors for recurrent TB in 
the form of systematic reviews and meta-analyses. 
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